MedTrace Logo

Focal Therapy for Localized Prostate Cancer

NCT03970863 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-02-09

No results posted yet for this study

Summary

To evaluate the cancer control for prostate cancer patients treated with focal therapy.

Conditions

Interventions

DIAGNOSTIC_TEST

Prostate Health Index

Use Prostate Health Index for the follow-up after focal therapy.

Sponsors & Collaborators

  • China Medical University Hospital

    lead OTHER

Principal Investigators

  • Po-Fan Hsieh · China Medical University Hospital

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2020-11-10
Completion
2021-11-10

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03970863 on ClinicalTrials.gov